MarketBeat on MSN
Tarsus Pharmaceuticals enters retina market with iRenix deal, adds IRX-101 to pipeline
Key Points Interested in Tarsus Pharmaceuticals, Inc.? Here are five stocks we like better. Tarsus Pharmaceuticals closed its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results